secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001104659-22-129882
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics raises $25M in registered direct offering at $0.8784/share
-------------------------------------------------------------------------------

- Registered direct offering of 28,460,831 shares at $0.8784 per share for gross proceeds of ~$25M.
- Largest stockholder GMS Ventures participated in the offering.
- Net proceeds to support ONS-5010 development program and working capital; may include debt repayment.
- Offering expected to close December 28, 2022; M.S. Howells & Co. acted as placement agent.
- BTIG served as exclusive financial advisor to the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465922129882/0001104659-22-129882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465922129882/tm2233312d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-129882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer